The natural history of type 2 diabetes: Implications for clinical practice

Primary Care - Clinics in Office Practice

Volumn 26, Issue 4, 1999, Pages 771-790

  Ramlo Halsted, B A ^a   Edelman, S V ^a  

^a Div of Endocrinology and Metabolism   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0032743150     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(05)70130-5     Document Type: Article

References (33)

1. T. Antonucci R. Whitcomb R. McLain Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone Diabetes Care 20 1997 188 193
2. E. Bonora S. Kiechl J. Willeit Prevalence of insulin resistance in metabolic disorders: The Bruneck study Diabetes 47 1998 1643 1649
3. Consensus Statement: The pharmacologic treatment of hyperglycemia in NIDDM Diabetes Care 19 1996 354S 361S
4. R.A. DeFronzo A.M. Goodman the Multicenter Metformin Study Group Efficacy of metformin in patients with non–insulin-dependent diabetes mellitus N Engl J Med 333 1995 541 549
5. Diabetes Prevention Program Research Group Protocol for the diabetes prevention program, version 3.2 1998 George Washington University Biostatistics Center
6. B. Draznin J. Driscoll J. Sievers Troglitazone plus sulfonylurea combination: Long-term efficacy in patients with type 2 diabetes. [abstract 0330] Journal of the American Diabetes Association 47 1998 A85
7. S.V. Edelman Impaired glucose tolerance: A precursor of NIDDM or a disease entity in itself? Diabetes 16 1995 1 5
8. S.L. Edelstein W.C. Knowler R.P. Bain Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies Diabetes 46 1997 701 710
9. J. Eriksson A. Franssila-Kallunki A. Ekstrand Early metabolic defects in persons at increased risk for non–insulin-dependent diabetes mellitus N Engl J Med 321 1989 337 343
10. K.F. Eriksson F. Lindgarde Poor physical fitness, and impaired early insulin response but late hyperinsulinemia as predictors of NIDDM in middle-aged Swedish men Diabetologia 39 1996 573 579
11. K.F. Eriksson F. Lindgarde Prevention of type 2 (non–insulin-dependent) diabetes mellitus by diet and physical exercise: The 6-year Malmo Feasibility Study Diabetologia 34 1991 891 898
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1997 1183 1197
13. T.C. Fagan P.C. Deedwania The cardiovascular dysmetabolic syndrome Am J Med 105 1998 77 82S
14. S.M. Haffner M.P. Stern H.P. Hazuda Cardiovascular risk factors in confirmed prediabetic individuals: Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263 1990 2893 2898
15. M.I. Harris Consultant 37 1997 S9 S14
16. M.I. Harris Impaired glucose tolerance in the US population Diabetes Care 12 1989 464 474
17. M.I. Harris W.C. Hodden W.C. Knowler Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20–74 years Diabetes 36 1987 523 524
18. A.D.B. Harrower Comparison of efficacy, secondary failure rate, and complications of sulfonylureas J Diabetes Complications 8 1994 201 203
19. R.R. Henry Type 2 diabetes care: The role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention Am J Med 105 1998 20 26S
20. E. Horton F. Whitehouse M.N. Ghazzi Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes Diabetes Care 21 1998 1462 1468
21. W.A. Hsueh R.E. Law Cardiovascular risk continuum: Implication of insulin resistance and diabetes Am J Med 105 1998 4 14S
22. J.L. Leahy Natural history of beta-cell dysfunction in NIDDM Diabetes Care 13 1990 992 1010
23. S.D. Long K. O'Brien K.G. MacDonald Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes Diabetes Care 17 1994 372 375
24. Y. Matsuzawa Pathophysiology and molecular mechanisms of visceral fat syndrome Diabetes Metab Rev 13 1997 3 13
25. D.R. Matthews C.A. Cull I.M. Stratton UKPDS 26: Sulphonylurea failure in non–insulin-dependent diabetic patients over six years Diabet Med 15 1998 297 303
26. J.B. McPhillips E. Barrett-Connor D.L. Wingard Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non–insulin-dependent diabetes mellitus in a community of older adults Am J Epidemiology 131 1990 443 453
27. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Statistics 1995 1 4 NIH Publ No 96-3926
28. J.J. Nolan B. Ludvik P. Beerdsen Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone N Engl J Med 331 1994 1188 1193
29. I.J. Perry S.G. Wannamethee M.K. Walker Prospective study of risk factors for development of non–insulin-dependent diabetes in middle aged British men BMJ 310 1995 560 564
30. M. Rewers R.F. Hamman Risk factors for non–insulin-dependent diabetes Diabetes in America ed 2 1995 National Institutes of Health, National Institutes of Diabetes, Digestive and Kidney Diseases (NIH Publication No. 95-1468)
31. N. Ruderman D. Chisholm X. Pi-Sunyer The metabolically obese, normal-weight individual revisited Diabetes 47 1998 699 713
32. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
33. J.H. Warram B.C. Martin A.S. Krolewski Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents Ann Intern Med 113 1990 909 915